Filippo Belardelli focuses on Immunology, Immune system, Cytokine, Interferon and Dendritic cell. His study in Acquired immune system, Virus, CC chemokine receptors, Monocyte and Interferon type I is carried out as part of his Immunology studies. The study incorporates disciplines such as Cancer, Antibody and Alpha interferon in addition to Immune system.
Filippo Belardelli has included themes like T lymphocyte, Cellular differentiation, Host response, Immune regulation and CCL18 in his Cytokine study. His biological study spans a wide range of topics, including Cancer research, Peritoneal cavity, CXCL10, TLR3 and Pattern recognition receptor. His study in Dendritic cell is interdisciplinary in nature, drawing from both C-C chemokine receptor type 7, Interleukin 12, Interleukin 15 and Antigen-presenting cell.
His main research concerns Immunology, Immune system, Interferon, Virology and Cell biology. His work in Immunology addresses issues such as Cancer, which are connected to fields such as Clinical trial. His Immune system study frequently intersects with other fields, such as Spleen.
His Interferon research includes themes of Molecular biology, Cancer research and Friend leukemia. His Virology research incorporates elements of Adjuvant, In vitro and Antibody. His work carried out in the field of Cell biology brings together such families of science as Receptor, IL-2 receptor and Cellular differentiation.
His primary areas of study are Immunology, Immune system, Immunotherapy, Cancer and Cell biology. Dendritic cell, Cancer immunotherapy, CD8, Antigen-presenting cell and Antigen are the primary areas of interest in his Immunology study. His studies in Immune system integrate themes in fields like Interferon, Cell and Melanoma.
The various areas that Filippo Belardelli examines in his Immunotherapy study include Combination therapy, Dacarbazine and Oncology. His research in Cancer intersects with topics in Cancer research, Clinical trial, Cyclophosphamide, Family medicine and Adjuvant. His research on Cell biology also deals with topics like
Filippo Belardelli mostly deals with Immunology, Immune system, Cell biology, Immunotherapy and Acquired immune system. His Immunology research is multidisciplinary, relying on both Cancer and Cytotoxic T cell. His study in Immune system is interdisciplinary in nature, drawing from both Interferon, Melanoma and Cytokine.
His Cell biology research includes themes of In vitro, IL-2 receptor, CD40, Immunosurveillance and Transcription factor. Filippo Belardelli focuses mostly in the field of Immunotherapy, narrowing it down to topics relating to Dacarbazine and, in certain cases, T-cell receptor. The various areas that Filippo Belardelli examines in his Acquired immune system study include Chemokine, Innate immune system and Cell growth.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.
Agnes Le Bon;Giovanna Schiavoni;Giuseppina D'Agostino;Ion Gresser.
Type I Interferon as a Powerful Adjuvant for Monocyte-Derived Dendritic Cell Development and Activity in Vitro and in Hu-Pbl-Scid Mice
Stefano M. Santini;Caterina Lapenta;Mariantonia Logozzi;Stefania Parlato.
Journal of Experimental Medicine (2000)
Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer
L Bracci;G Schiavoni;A Sistigu;F Belardelli.
Cell Death & Differentiation (2014)
Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
Antonella Sistigu;Takahiro Yamazaki;Erika Vacchelli;Kariman Chaba.
Nature Medicine (2014)
Role of interferons and other cytokines in the regulation of the immune response.
Type I interferons produced by dendritic cells promote their phenotypic and functional activation.
Maria Montoya;Giovanna Schiavoni;Fabrizio Mattei;Ion Gresser.
IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation.
Fabrizio Mattei;Giovanna Schiavoni;Filippo Belardelli;David F. Tough.
Journal of Immunology (2001)
The neglected role of type I interferon in the T-cell response: implications for its clinical use
Filippo Belardelli;Ion Gresser.
Immunology Today (1996)
ICSBP Is Essential for the Development of Mouse Type I Interferon-producing Cells and for the Generation and Activation of CD8α+ Dendritic Cells
Giovanna Schiavoni;Fabrizio Mattei;Paola Sestili;Paola Borghi.
Journal of Experimental Medicine (2002)
Effect of Proton Pump Inhibitor Pretreatment on Resistance of Solid Tumors to Cytotoxic Drugs
Francesca Luciani;Massimo Spada;Angelo De Milito;Agnese Molinari.
Journal of the National Cancer Institute (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: